Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 3, 1997, Pages 727-734

  Johannsson, Gudmundur ^a   Mårin, Per ^a   Lönn, Lars ^a   Ottosson, Malin ^a   Stenlöf, Kaj ^a   Björntorp, Per ^a   Sjöström, Lars ^a   Bengtsson, Bengt Åke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; PLACEBO; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; AGED; ARTHRALGIA; ARTICLE; BODY FAT; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EDEMA; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HYPERHIDROSIS; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; MALE; MUSCLE STIFFNESS; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADIPOSE TISSUE; AGED; BLOOD PRESSURE; BODY COMPOSITION; DIASTOLE; DOUBLE-BLIND METHOD; GLUCOSE; HORMONES; HUMAN GROWTH HORMONE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; OBESITY; RADIOGRAPHY, ABDOMINAL; RECOMBINANT PROTEINS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031057076     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.3.727     Document Type: Article

References (50)

1. Björntorp P. 1993 Visceral obesity: a "Civilization Syndrome". Obesity Research. 1:206-222.
2. Reaven GH. 1988 Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
3. Bengtsson B-Å. 1993 The consequences of growth hormone deficiency in adults. Acta Endocrinol (Copenh). [Suppl] 2)128:2-5.
4. Reaven GM. 1995 Pathophysiology of insulin resistance in human disease. Physiol Rev. 75:473-486.
5. Salomon F, Cuneo RC, Hesp R, Sönksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
6. Johansson J-O, Fowelin J, Landin K, Lager I, Bengtsson B-Å. 1995 Growth hormone-deficient adults are insulin-resistant. Metabolism. 44:1126-1129.
7. Rosén T, Edén S, Larsson G, Wilhelmsen L, Bengtsson B-Å. 1993 Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 129:195-200.
8. Johansson J-O, Landin K, Tengborn L, Rosén T, Bengtsson B-Å. 1994 High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb. 14:434-437.
9. Markussis V, Beshyam SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. 1992 Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 340:1188-1192.
10. MSrin P, Björntorp P. 1993 Endocrine-metabolic pattern and adipose tissue distribution. Horm Res. [Suppl 3]39:81-85.
11. Rosén T, Bengtsson B-Å. 1990 Premature mortality due to cardiovascular diseases in hypopituitarism. Lancet. 336:285-388.
12. Mårin P, Darin N, Amemiya T, Andersson B, Jern S, Bjömtorp P. 1992 Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism. 41:882-886.
13. Mårin P, Kvist H, Lindstedt G, Sjöström L, Björntorp P. 1993 Low concentrations of insulin-like growth factor-I in abdominal obesity. Int J Obes. 17:83-89.
14. Mårin P, Holmäng S, Gustafsson C, et al. 1993 Androgen treatment of abdominally obese men. Obes Res. 1:245-251.
15. Veldhuis JD, Liem AY, South S, et al. 1995 Differential impact of age, sex steroid hormones, and obesity on basal vs. pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 80:3209-3222.
16. Hartman ML, Clayton PE, Johnson ML, et al. 1993 A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest. 91:2453-2462.
17. De Boer H, Blok G-J, Van der Veen EA. 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 16:63-86.
18. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. 1994 Serum insulin-like growth factor I in a random population sample of men and women: relationship to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf). 41:351-357.
19. 40K. Int J Obes. 12:249-266.
20. Chowdhury B, Sjöström L, Alpsten M, Konstanty J, Kvist H, Löfgren R. 1994 A multicompartment body composition technique based on computed tomography. Int J Obes. 18:219-234.
21. Bengtsson-Olivecrona G, Olivecrona T. 1992 Lipoprotein analysis-a practical approach. In: Converse CA, Skinner ER, eds. Practical approach series. Oxford: Oxford University Press; 169-185.
22. Dole VP, Meinertz H. 1960 Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem. 235:2595-2599.
23. Friberger P, Knös M, Gustavsson S, Aurell L, Claeson G. 1978 Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis. 7:138-145.
24. Larsson B, Seidell J, Svärdsudd K, et al. 1989 Obesity, adipose tissue distribution and health in men. The study of men born in 1913. Appetite. 13:37-44.
25. Marcus R, Butterfield G, Holloway L, et al. 1990 Effects of short-term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab. 70:519-527.
26. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab. 79:470-479.
27. Rudman D, Feller AG, Nagraj HS, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
28. Bengtsson B-Å, Edén S, Lönn L, et al. 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 76:309-317.
29. Rosenbaum M, Gertner JM, Leibel R. 1989 Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab. 69:1274-1281.
30. Bolli GB, Gerich JE. 1984 The "dawn phenomonon"-A common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med. 310:746-750.
31. Fowelin J, Attvall S, von Schenk H, Smith U, Lager I. 1989 Combined effect of growth hormone and cortisol on late posthypoglycaemic insulin resistance in humans. Diabetes. 38:1357-1364.
32. Fowelin J, Attvall S, Lager I, Bengtsson B-Å. 1993 Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism. 42:1443-1447.
33. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J. 1985 Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent diabetes mellitus. J Clin Invest. 76:149-155.
34. Lund S, Flyvbjerg A, Holman GD, Larsen FS, Pedersen O, Schmitz O. 1994 Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle. Am J Physiol. 267:E461-E466.
35. Ayling CM, Moreland BH, Zanelli JM, Schulster D. 1989 Human growth hormone treatment of hypophysectomized rats increases the proportion of type-1 fibres in skeletal muscle. J Endocrinol. 123:429-435.
36. Rudling M, Norstedt G, Olivecrona H, Reihnér E, Gustafsson J-Å, Angelin B. 1992 Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA. 89:6983-6987.
37. Angelin B, Rudling M. 1994 Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol. 5:160-165.
38. Elam MB, Wilcox HG, Salomon SS, Heimberg M. 1992 In vivo growth hormone treatment stimulates secretion of very low density lipoproteins by the perfused rat liver. Endocrinology. 131:2717-2722.
39. Richelsen B, Pedersen SB, Børglum JD, Meller-Pedersen T, Jørgensen J, Jørgensen JO. 1994 Growth hormone treatment of obese women for 5 wk; effect on body composition and adipose tissue LPL activity. Am J Physiol. 266:E211-E216.
40. Caidahl K, Edén S, Bengtsson B-Å. 1994 Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf). 40:393-400.
41. Reaven GM, Lithell H, Landsberg L. 1996 Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 334:374-381.
42. Copeland KC, Nair KS. 1994 Recombinant human insulin-like growth factor-I increases forearm blood flow. J Clin Endocrinol Metab. 79:230-232.
43. Vague P, Juhan-Vague I, Aillaud MF, et al. 1986 Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism. 35:250-253.
44. Landin K, Stigendal L, Eriksson E, et al. 1990 Abdominal obesity is associated with impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism. 39:1044-1048.
45. Hamsten A, de Faire U, Walldius G, et al. 1987 Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 2:3-9.
46. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. 1984 Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 311:501-505.
47. Johansson J-O, Landin K, Johannsson G, Tengborn L, Bengtsson B-Å. 1996 Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Thromb Haemost. 76:422-428.
48. MŚrin P, Holmäng S, Jönsson L, et al. 1992 The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes. 16:991-997.
49. Liu L, Merriam GR, Sherins RJ. 1987 Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 64:651-656.
50. Yang S, Xu X, Björntorp P, Edén S. 1995 Additive effects of growth hormone and testosterone on lipolysis in adipocytes of hypophysectomized rats. J Endocrinol. 147:147-152.